Evidence for dopamine agonists in the treatment of acromegaly.
Jaquet
P
P
Department of Endocrinology, Hôpital D'Adultes de la Timone, Marseilles, France.
D000172:Acromegaly / Q000188:drug therapy* / Q000209:etiology; D000236:Adenoma / Q000150:complications / Q000188:drug therapy; D000634:Aminoquinolines / Q000627:therapeutic use; D001971:Bromocriptine / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D015282:Octreotide / Q000627:therapeutic use; D010911:Pituitary Neoplasms / Q000150:complications / Q000188:drug therapy; D013004:Somatostatin / Q000031:analogs & derivatives
D000634:Aminoquinolines; D018491:Dopamine Agonists; D001971:Bromocriptine; D013004:Somatostatin; C046650:quinagolide; D015282:Octreotide